BioPlus Co Ltd
KOSDAQ:099430
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Macy's Inc
XETRA:FDO
|
US |
BioPlus Co Ltd
Accounts Payable
BioPlus Co Ltd
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Accounts Payable
₩1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Accounts Payable
₩26.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
6%
|
|
|
SD Biosensor Inc
KRX:137310
|
Accounts Payable
₩49.3B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Accounts Payable
₩8.7B
|
CAGR 3-Years
39%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
12%
|
|
|
O
|
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
|
Accounts Payable
₩2.7B
|
CAGR 3-Years
19%
|
CAGR 5-Years
23%
|
CAGR 10-Years
0%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Accounts Payable
₩7.1B
|
CAGR 3-Years
119%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
BioPlus Co Ltd
Glance View
BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.
See Also
What is BioPlus Co Ltd's Accounts Payable?
Accounts Payable
1B
KRW
Based on the financial report for Dec 31, 2024, BioPlus Co Ltd's Accounts Payable amounts to 1B KRW.
What is BioPlus Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
22%
Over the last year, the Accounts Payable growth was 67%. The average annual Accounts Payable growth rates for BioPlus Co Ltd have been 1% over the past three years , 22% over the past five years .
